IDH1 and central nervous system cancer: Violin analysis for the distribution of GlioPredictor score in cohorts of WHO Grade 2 and 3 glioma patients in TCGA dataset with mutated IDH1 (TCGA-IDH1_MT), with wildtype IDH1 (TCGA-IDH1_WT), and TCGA-Glioblastoma with wildtype IDH1 (TCGA-GBM IDH1_WT) showed significantly different pattern of distribution with mean GlioPredictor score of 79, 27, and 6, respectively (Fig. 6A, p < 0.001).